GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GHRS is expected to report earnings to rise 17.87% to -27 cents per share on February 26
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.16
Q4'24
Beat
by $0.05
The last earnings report on November 06 showed earnings per share of -23 cents, beating the estimate of -23 cents. With 1.42M shares outstanding, the current market capitalization sits at 851.04M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GHRS showed earnings on November 06, 2025. You can read more about the earnings report here.